Teresa R Gray - Concepedia

Author

Teresa R Gray

National Institute on Drug Abuse

Also Known As

Teresa Gray, Teresa R Gray, Teresa R. Gray

Publications

976

Citations

H-Index

Concepts

All Affiliations

National Institute on Drug Abuse National Institutes of Health University of Hawaiʻi at Mānoa Blank Children's Hospital University of Maryland, College Park

About

Teresa R Gray is an author at National Institute on Drug Abuse specializing in medicine, pharmacology, and drug analysis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	428
2	Health Sciences	3	3	71
3	Biochemistry	2	2	122
4	Public Health	1	1	45
5	Chemistry	1	1	39

Teresa R Gray

Publications

802

Citations

H-Index

Page 1

	Year	Citations
Identifying Prenatal Cannabis Exposure and Effects of Concurrent Tobacco Exposure on Neonatal Growth Teresa R Gray, Rina D. Eiden, Kenneth E. Leonard, Clinical Chemistry	2010	137
A liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 20 drugs of abuse and metabolites in human meconium Teresa R Gray, Diaá M. Shakleya, Marilyn A. Huestis Analytical and Bioanalytical Chemistry BiochemistryGas ChromatographyMedicineDrug PurityBioanalysis	2009	63
Quantification of nicotine, cotinine, trans-3′-hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography/tandem mass spectrometry Teresa R Gray, Diaá M. Shakleya, Marilyn A. Huestis Journal of Chromatography B BiochemistryGas ChromatographyMedicineNicotineBioanalysis	2008	59
High-throughput simultaneous analysis of buprenorphine, methadone, cocaine, opiates, nicotine, and metabolites in oral fluid by liquid chromatography tandem mass spectrometry Marta Concheiro, Teresa R Gray, Diaá M. Shakleya, Analytical and Bioanalytical Chemistry Substance AbuseMedicineDrug PurityForensic ToxicologyMass Spectrometry	2010	59
Methadone, Cocaine, Opiates, and Metabolite Disposition in Umbilical Cord and Correlations to Maternal Methadone Dose and Neonatal Outcomes Ana de Castro, Hendrée E. Jones, Rolley E. Johnson, Therapeutic Drug Monitoring	2011	53
Maternal Methadone Dose, Placental Methadone Concentrations, and Neonatal Outcomes Ana de Castro, Hendrée E. Jones, Rolley E. Johnson, Clinical Chemistry	2011	53
Identification of Prenatal Amphetamines Exposure by Maternal Interview and Meconium Toxicology in the Infant Development, Environment and Lifestyle (IDEAL) Study Teresa R Gray, Linda L. LaGasse, Lynne M. Smith, Therapeutic Drug Monitoring Substance UsePrenatal Amphetamines ExposureMaternal Mamp ExposureDrug TestToxicology	2009	48
Changes in Smoking Patterns During Pregnancy Rina D. Eiden, Gregory G. Homish, Craig R. Colder, Substance Use & Misuse Tobacco CessationSubstance UseReproductive HealthGynecologySocial Determinants Of Health	2013	45
Case Reports of Fatalities Involving Tianeptine in the United States Erica L. Bakota, Warren C. Samms, Teresa R Gray, Journal of Analytical Toxicology First CasePharmacotherapyTianeptine IntoxicationFatalities Involving TianeptineTianeptine Powder	2018	43
Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome Teresa R Gray, Robin E. Choo, Marta Concheiro, Addiction	2010	41

Page 1